“SEMAGLUTIDE: A POTENTIAL WEIGHT LOSS DRUG FOR OBESE PATIENTS”, Northwest J Med Sci, vol. 2, no. 1, Apr. 2023, doi: 10.69723/njms.02.01.0315.